CD8A and Miyoshi myopathy: Administration of AMD3100 was also associated with increased CD8+ T cell infiltration and synergistic activity when combined with ICI (171) Use of AMD3100 in NHL and MM suppressed tumor growth and metastasis and was associated with converting Tregs to a Th1 phenotype and enhancing CD8+ T cell infiltration (172).